Clearstate’s study of the Molecular Diagnostics (MDx) market in South East Asia covering Thailand, Malaysia, Singapore, Indonesia, Philippines and Vietnam reveals that the region’s MDx market reached USD 17 – 19 million in 2008.
In 2008, the market experienced a strong growth of ~12%. This market is set to continue growing at a rapid pace of 10% CAGR from 2009 to 2013.